Metastasis-Associated Protein 2 Represses NF-κB to Reduce Lung Tumor Growth and Inflammation

Area of Science:

• Oncology
• Epigenetics
• Molecular Biology

Background:

• Nuclear factor-kappa B (NF-κB) signaling is crucial in lung cancer development, influencing tumor growth, metastasis, and the tumor microenvironment.
• The epigenetic regulation of NF-κB within the tumor context remains largely uncharacterized.
• Metastasis-associated protein 2 (MTA2) is a component of the nucleosome remodeling and deacetylase (NuRD) complex.

Purpose of the Study:

• To investigate the epigenetic regulation of NF-κB signaling in lung cancer.
• To elucidate the role of MTA2 in the context of IKK2/NF-κB signaling during lung tumor progression.
• To understand the biphasic function of MTA2 in primary tumor growth and metastasis.

Main Methods:

• Utilized triple transgenic mouse models with specific genetic manipulations of IKK2 (inhibitor and activator).
• Assessed tumor formation and growth in response to IKK2 modulation.
• Employed genetic inhibition of MTA2 to study its role in primary tumor growth and metastasis.
• Investigated the interaction between MTA2/NuRD complex and NF-κB target genes.

Main Results:

• Downregulation of IKK2 restricted tumor formation, while IKK2 activation promoted tumor growth, with corresponding alterations in MTA2 expression.
• MTA2, via the NuRD complex, negatively regulated NF-κB signaling and primary tumor growth independently of IKK2.
• Later, IKK2-dependent regulation of MTA2 and dissociation of the MTA2/NuRD complex activated NF-κB signaling, promoting epithelial-mesenchymal transition and lung metastasis.

Conclusions:

• MTA2 exhibits a previously unrecognized biphasic role in IKK2/NF-κB-driven lung tumor progression from primary growth to metastasis.
• The interplay between MTA2 and NF-κB signaling presents potential therapeutic targets for lung cancer intervention.
• MTA2 significantly modulates primary tumor growth, lung metastasis, and NF-κB signaling pathways.